| Literature DB >> 29898088 |
Cristian Roncada1, Thiago de Araujo Cardoso2, Bianca Martininghi Bugança3, Luísa Carolina Bischoff3, Karina Soldera3, Paulo Márcio Pitrez2.
Abstract
OBJECTIVE: To evaluate the levels of knowledge about asthma of parents of school children.Entities:
Mesh:
Year: 2018 PMID: 29898088 PMCID: PMC6063748 DOI: 10.1590/S1679-45082018AO4204
Source DB: PubMed Journal: Einstein (Sao Paulo) ISSN: 1679-4508
Characteristics of 154 parents, divided by groups
| Characteristic | Asthma Group (n=62) | Control Group (n=92) | p value | |||
|---|---|---|---|---|---|---|
| n (%) | M±SD | n (%) | M±SD | |||
| Parents | ||||||
| Age | 36.19±9.22 | 35.20±10.57 | 0.547 | |||
| Female | 57 (91.9) | 75 (81.5) | 0.055 | |||
| Schooling | ||||||
| Elementary school | 9 (14.5) | 8 (8.7) | ||||
| Junior school | 12 (19.4) | 21 (22.8) | 0.071 | |||
| High School | 36 (58.1) | 52 (56.5) | ||||
| Further education | 5 (8.1) | 11 (12.0) | ||||
M: mean; SD: standard deviation. Student t test was used for continuous variables and χ2 for categorical variables.
Evaluation of the total and percentage of parents who matched each item, between the Asthma Group and Control Group
| Item | Answers | Asthma Group n=62 n (%) | Control Group n=92 n (%) | p value |
|---|---|---|---|---|
| 1 | Cough, wheezing and shortness of breath or dyspnea | 27 (43.5) | 30 (32.6) | 0.110 |
| 2 | True | 50 (80.6) | 65 (70.7) | 0.110 |
| 3 | True | 54 (87.1) | 78 (84.8) | 0.440 |
| 4 | False | 35 (56.5) | 75 (81.5) | 0.001 |
| 5 | False | 52 (83.9) | 37 (40.2) | <0.001 |
| 6 | Allergy, cold and exercise | 55 (88.7) | 70 (76.1) | 0.037 |
| 7 | True | 42 (67.7) | 64 (69.6) | 0.470 |
| 8 | True | 50 (80.6) | 63 (68.5) | 0.070 |
| 9 | False | 24 (38.7) | 25 (27.2) | 0.090 |
| 10 | Write down the names of two types of treatments (medications) that should be regularly taken to prevent asthma exacerbations: inhaled corticosteroids, leukotriene-receptor antagonist (montelukast), long-acting beta-2 adrenergic agonists | 44 (71.0) | 38 (41.3) | <0.001 |
| 11 | Write down the names of three treatments (medications) that are useful during asthma exacerbation: short-acting beta-2 adrenergic agonists, ipratropium bromide or oral corticosteroids | 50 (80.6) | 42 (45.7) | <0.001 |
| 12 | False | 27 (43.5) | 26 (28.3) | 0.0370 |
| 13 | False | 43 (69.4) | 42 (45.7) | 0.003 |
| 14 | False | 47 (75.8) | 82 (89.1) | 0.025 |
| 15 | False | 31 (50.0) | 41 (44.6) | 0.3 |
| 16 | False | 35 (56.5) | 43 (46.7) | 0.1 |
| 17 | False | 60 (96.8) | 89 (96.7) | 0.68 |
| 18 | True | 15 (24.2) | 23 (25.0) | 0.53 |
| 19 | False | 30 (48.4) | 35 (38.0) | 0.13 |
| 20 | False | 24 (38.7) | 45 (48.9) | 0.13 |
| 21 | A 5-year old child has an asthma exacerbation and uses 2 puffs of inhaled salbutamol (inhaler). Five minutes later, the patient is not getting better. Write down some possible reasons for what happened: insufficient dose, very severe exacerbation, poor inhaling technique or empty device | 14 (22.6) | 20 (21.7) | 0.52 |
| 22 | False | 14 (22.6) | 13 (14.1) | 0.120 |
| 23 | Write down ways that help preventing asthma exacerbation during exercises: short-acting beta-2 adrenergic agonists before exercise, improve asthma control (appropriate drug prophylaxis) or physical warming up | 13 (21.0) | 22 (23.9) | 0.410 |
| 24 | False | 33 (53.2) | 57 (62.0) | 0.180 |
| 25 | False | 36 (58.1) | 63 (68.5) | 0.120 |
| 26 | True | 57 (91.9) | 83 (90.2) | 0.470 |
| 27 | True | 55 (88.7) | 81 (88.0) | 0.550 |
| 28 | False | 22 (35.5) | 35 (38.0) | 0.440 |
| 29 | True | 48 (77.4) | 68 (73.9) | 0.380 |
| 30 | False | 52 (83.9) | 55 (59.8) | 0.001 |
| 31 | True | 59 (95.2) | 73 (79.3) | 0.004 |
| Total of acceptable levels | ≥21 | 26 (41.9) | 21 (22.8) | 0.010 |
Total number of parents that achieved acceptable levels of knowledge, considering the total score of the tool (cut-off point ≥21 points).
p<0.05. The χ2 test was used to compare categorical variables between the Asthma and Control Groups.
Figure 1Mean scores of groups and subgroups
*p<0.05;† healthy versus moderate asthma; φ asthma in remission versus moderate asthma.
Figure 2Evaluation of levels of knowledge about asthma (acceptable levels) among groups and subgroups
* p<0.05.